Shopping Cart
- Remove All
- Your shopping cart is currently empty
RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $293 | In Stock | |
5 mg | $722 | In Stock | |
10 mg | $987 | In Stock | |
25 mg | $1,520 | In Stock | |
50 mg | $1,980 | In Stock | |
100 mg | $2,500 | In Stock |
Description | RLX is a PI3K/Akt/FoxO3a signaling inhibitor in experimental colon cancer. |
Alias | THA-Q, THA Q, PD-139530, PD139530, PD 139530 |
Cas No. | 4425-23-4 |
Smiles | O=C1N2CCCCCC2=NC2=C1C=CC=C2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.